Terms: = Prostate cancer AND MUC1, PEM, 4582, ENSG00000185499, PUM, MAM6, EMA, CD227, H23AG
220 results:
1. Repurposing sodium stibogluconate as an uracil DNA glycosylase inhibitor against prostate cancer using a time-resolved oligonucleotide-based drug screening platform.
Nao SC; Huang LS; Shiu-Hin Chan D; Wang X; Li GD; Wu J; Wong CY; Wang W; Leung CH
Bioorg Chem; 2024 Mar; 144():107176. PubMed ID: 38330721
[TBL] [Abstract] [Full Text] [Related]
2. Gelatinous Pleural Effusion: A Diagnostic Challenge for Pleural Mesothelioma in an 80-Year-Old Man.
Ibnian AM; Khan OU; Chan R; Bangalore Lakshminarayana U; Kiran F; Abed S; Abbas R; Amir A; Al-Kofahi NK
Am J Case Rep; 2023 Oct; 24():e941263. PubMed ID: 37793939
[TBL] [Abstract] [Full Text] [Related]
3. Tandem CAR-T cells targeting muc1 and PSCA combined with anti-PD-1 antibody exhibit potent preclinical activity against non-small cell lung cancer.
Wang A; Lv T; Song Y
Cell Immunol; 2023; 391-392():104760. PubMed ID: 37660477
[TBL] [Abstract] [Full Text] [Related]
4. A Model for Gastric cancer Risk Prediction Based on
Nguyen NT; Dang NDT; Vu QV; Dang AK; Ta TV
In Vivo; 2023; 37(5):2347-2356. PubMed ID: 37652501
[TBL] [Abstract] [Full Text] [Related]
5. Poly-ADP ribose polymerase inhibitor and androgen receptor signaling inhibitor for all comers for first-line treatment of metastatic castration-resistant prostate cancer: is gene sequencing out?
Higano CS; Cheng HH
Curr Opin Urol; 2023 Sep; 33(5):396-403. PubMed ID: 37497748
[TBL] [Abstract] [Full Text] [Related]
6. Canonical and truncated transglutaminase-2 regulate mucin-1 expression and androgen independency in prostate cancer cell lines.
Atobatele AG; Tonoli E; Vadakekolathu J; Savoca MP; Barr M; Kataria Y; Rossanese M; Burhan I; McArdle S; Caccamo D; Verderio EAM
Cell Death Dis; 2023 May; 14(5):317. PubMed ID: 37160910
[TBL] [Abstract] [Full Text] [Related]
7. [Lutetium-177-PSMA in metastasized prostate carcinoma].
van Golen LW; Vogel W; Lam MGEH
Ned Tijdschr Geneeskd; 2023 Mar; 167():. PubMed ID: 36943158
[TBL] [Abstract] [Full Text] [Related]
8. [Lutetium-177-PSMA in metastasized prostate carcinoma].
van Golen LW; Vogel W; Lam MGEH
Ned Tijdschr Geneeskd; 2023 Mar; 166():. PubMed ID: 36927799
[TBL] [Abstract] [Full Text] [Related]
9. Dependence on muc1-C in Progression of Neuroendocrine prostate cancer.
Kufe D
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835130
[TBL] [Abstract] [Full Text] [Related]
10. Adoption of Lutetium-
Flegar L; Thoduka SG; Librizzi D; Luster M; Zacharis A; Heers H; Eisenmenger N; Ahmadzadehfar H; Eiber M; Weber W; Groeben C; Huber J
Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):2188-2195. PubMed ID: 36826478
[TBL] [Abstract] [Full Text] [Related]
11. Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancer.
Sayar E; Patel RA; Coleman IM; Roudier MP; Zhang A; Mustafi P; Low JY; Hanratty B; Ang LS; Bhatia V; Adil M; Bakbak H; Quigley DA; Schweizer MT; Hawley JE; Kollath L; True LD; Feng FY; Bander NH; Corey E; Lee JK; Morrissey C; Gulati R; Nelson PS; Haffner MC
JCI Insight; 2023 Apr; 8(7):. PubMed ID: 36821396
[TBL] [Abstract] [Full Text] [Related]
12. Novel nomogram developed for determining suitability of metastatic castration-resistant prostate cancer patients to receive maximum benefit from radium-223 dichloride treatment-Japanese Ra-223 Therapy in prostate cancer using Bone Scan Index (J-RAP-BSI) Trial.
Kitajima K; Igeta M; Kuyama J; Kawahara T; Suga T; Otani T; Sugawara S; Kono Y; Tamaki Y; Seko-Nitta A; Ishiwata Y; Ito K; Toriihara A; Watanabe S; Hosono M; Miyake H; Yamamoto S; Narita M; Daimon T; Yamakado K
Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1487-1498. PubMed ID: 36539508
[TBL] [Abstract] [Full Text] [Related]
13. prostate cancer Secretome and Membrane Proteome from
Santos NJ; Camargo ACL; Carvalho HF; Justulin LA; Felisbino SL
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012492
[TBL] [Abstract] [Full Text] [Related]
14. Association of germline TYK2 variation with lung cancer and non-Hodgkin lymphoma risk.
Yarmolinsky J; Amos CI; Hung RJ; Moreno V; Burrows K; Smith-Byrne K; Atkins JR; Brennan P; ; McKay JD; Martin RM; Davey Smith G
Int J Cancer; 2022 Dec; 151(12):2155-2160. PubMed ID: 35747941
[TBL] [Abstract] [Full Text] [Related]
15. The role of epithelial membrane antigen (ema) overexpression in the prognosis of prostatic adenocarcinoma.
Ghalib R; Falah A
J Med Life; 2022 Apr; 15(4):504-508. PubMed ID: 35646176
[TBL] [Abstract] [Full Text] [Related]
16. Chemical Interrogation of Nuclear Size Identifies Compounds with cancer Cell Line-Specific Effects on Migration and Invasion.
Tollis S; Rizzotto A; Pham NT; Koivukoski S; Sivakumar A; Shave S; Wildenhain J; Zuleger N; Keys JT; Culley J; Zheng Y; Lammerding J; Carragher NO; Brunton VG; Latonen L; Auer M; Tyers M; Schirmer EC
ACS Chem Biol; 2022 Mar; 17(3):680-700. PubMed ID: 35199530
[No Abstract] [Full Text] [Related]
17. Genome-wide association study of serum tumor markers in Southern Chinese Han population.
Li X; Bai F; Wei X; Jin T; Li C; Zhang Y; Lin M; Zhou X; Xie Y; He C; Lin Q; He P; Chu S; Ding Y
BMC Cancer; 2022 Feb; 22(1):160. PubMed ID: 35144566
[TBL] [Abstract] [Full Text] [Related]
18. muc1-C integrates type II interferon and chromatin remodeling pathways in immunosuppression of prostate cancer.
Hagiwara M; Fushimi A; Bhattacharya A; Yamashita N; Morimoto Y; Oya M; Withers HG; Hu Q; Liu T; Liu S; Wong KK; Long MD; Kufe D
Oncoimmunology; 2022; 11(1):2029298. PubMed ID: 35127252
[TBL] [Abstract] [Full Text] [Related]
19. muc1-C Dictates JUN and BAF-Mediated Chromatin Remodeling at Enhancer Signatures in cancer Stem Cells.
Bhattacharya A; Fushimi A; Yamashita N; Hagiwara M; Morimoto Y; Rajabi H; Long MD; Abdulla M; Ahmad R; Street K; Liu S; Liu T; Kufe D
Mol Cancer Res; 2022 Apr; 20(4):556-567. PubMed ID: 35022313
[TBL] [Abstract] [Full Text] [Related]
20. Nanotechnology-based approaches for effective detection of tumor markers: A comprehensive state-of-the-art review.
Laraib U; Sargazi S; Rahdar A; Khatami M; Pandey S
Int J Biol Macromol; 2022 Jan; 195():356-383. PubMed ID: 34920057
[TBL] [Abstract] [Full Text] [Related]
[Next]
